Susmed (4263) · InitiativeFirst statedLatest Earnings presentation (2026-05-08): "Advanced"
Exploration of Disease Biomarkers through Eye-Tracking Analysis with Nagoya University
First written in FY2024. 1 of 2 entries say "Advanced", first in 2026-05-08. Latest entry: 2026-05-08.
2entries
3years
1from disclosures
How it moved
Same theme, other companies
Eye-Tracking-Based Disease Biomarker Discovery with Nagoya UniversityA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- 2026-05-08AdvancedEarnings presentation
「SMD104 (ADHD: eye-tracking analysis) App under development Paper published Selected for an AMED project」
The app related to the search for disease biomarkers through eye-tracking analysis with Nagoya University was disclosed as being under development, with a paper published. - FY2024First statedAnnual report
「The Company commenced an initiative with Nagoya University, Tokai National Higher Education and Research System, to discover disease biomarkers using eye-tracking technology. The initiative has been selected as part of AMED's “Industry-Academia-Government Collaborative Mission-Oriented Drug Discovery Technology Research Project.”」
The Company commenced the discovery of disease biomarkers using eye-tracking technology with Nagoya University, and the initiative was selected for AMED's Industry-Academia-Government Collaborative Mission-Oriented Drug Discovery Technology Research Project.